Oculogica provides EyeBOX®, an FDA‑cleared eye‑tracking platform that delivers an objective concussion screen in under a minute.
Funding
$7.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Concussion assessment often relies on subjective symptom checklists and variable clinical examinations, leading to inconsistent diagnoses across providers and settings.
Solution
Oculogica offers EyeBOX®, an FDA‑cleared eye‑tracking platform that provides an objective, rapid concussion screen. The system records eye movements while the patient follows visual stimuli and generates a detailed report in about ten seconds. Clinicians can use the report to communicate findings clearly with patients, families, payers, and other providers, improving diagnostic consistency. The technology is supported by 16 peer‑reviewed studies, demonstrating its clinical validity in emergency rooms, sports medicine clinics, and primary care practices.
Target Audience
Primary customers are emergency department physicians, sports medicine clinicians, and primary care providers who need fast, objective tools for concussion evaluation.
Features
- FDA‑cleared eye‑tracking hardware and software that captures precise ocular metrics in under a minute
- Automated analysis algorithm that produces a comprehensive concussion screening report within ten seconds
- Clinically validated across 16 peer‑reviewed studies, ensuring reliability and regulatory confidence
- Cloud‑based data storage with secure, HIPAA‑compliant transmission for easy integration into existing workflows
- Multi‑user dashboard that allows providers to compare results across patients and track diagnostic consistency